(Q77214821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Serum percent free prostate-specific antigen in metastatic prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

D W Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J L Noteboom

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

B A Blumenstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

W J Ellis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P H Lange

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R L Vessella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

366-371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Screening for prostatic carcinoma with prostate specific antigen: results of the second year.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Rate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer Detection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Cell-cell interaction in prostate gene regulation and cytodifferentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

Change in morphological and functional cytodifferentiation induced by seminal vesicle mesenchyme in cell suspensions of rat Dunning prostatic adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900240-4

7 January 2021

10.1016/S0090-4295(98)00240-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730445%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference